uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted July 04, 2017

FDA Warns Against Company's Unsafe Teething Tablets

On June 20, 2017, the FDA issued a warning letter to Raritan Pharmaceuticals, Inc. following a routine inspection of the facility when it found the company's Homeopathic Infant's Teething Tablets in violation of current good manufacturing practice (CGMP) regulations.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at